Cincinnati, OH5 Active Studies

Multiple Myeloma Clinical Trials in Cincinnati, OH

Find 5 actively recruiting multiple myeloma clinical trials in Cincinnati, OH. Connect with local research sites and explore new treatment options.

5
Active Trials
3
Sponsors
349
Enrolling

Recruiting Multiple Myeloma Studies in Cincinnati

RecruitingCincinnati, OHNCT03847467

Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

Randomized, placebo-controlled dose-ranging study of 2'-FL in IBD, Crohn's Disease (CD) and ulcerative colitis (UC). The overarching hypothesis is that 2'-FL supplementation in IBD will be safe and we...

116 participants
Children's Hospital Medical Center, Cincinnati
View Study Details
RecruitingCincinnati, OHNCT06974786

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

This is an open-label, multi-site, Phase II randomized trial with response-adaptive design for newly diagnosed multiple myeloma (NDMM) participants who have had prior induction therapy. The primary ob...

100 participants
SCRI Development Innovations, LLC
View Study Details
RecruitingCincinnati, OHNCT05972135

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients...

75 participants
SCRI Development Innovations, LLC
View Study Details
RecruitingCincinnati, OHNCT04925375

Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

There is no standard of care therapy for patients with granulomatous-lymphocytic interstitial lung disease (GLILD) seen in common variable immunodeficiency (CVID). Abatacept has recently looked promis...

38 participants
Children's Hospital Medical Center, Cincinnati
View Study Details
RecruitingCincinnati, OHNCT05642455

SPEARHEAD-3 Pediatric Study

This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers....

20 participants
Adaptimmune
View Study Details

About Multiple Myeloma Clinical Trials in Cincinnati

Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.

There are currently 5 multiple myeloma clinical trials recruiting participants in Cincinnati, OH. These studies are seeking a combined 349 participants. Research is being sponsored by Children's Hospital Medical Center, Cincinnati, SCRI Development Innovations, LLC, Adaptimmune. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Myeloma Clinical Trials in Cincinnati — FAQ

Are there multiple myeloma clinical trials in Cincinnati?

Yes, there are 5 multiple myeloma clinical trials currently recruiting in Cincinnati, OH. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Cincinnati?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cincinnati research site will contact you about next steps.

Are clinical trials in Cincinnati free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cincinnati studies also compensate for your time and travel.

What multiple myeloma treatments are being tested?

The 5 active trials in Cincinnati are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.

Data updated March 2, 2026 from ClinicalTrials.gov